Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Vagus nerve stimulation Stories

2012-04-02 02:27:34

LOS ANGELES, April 2, 2012 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, today announced its appointment of Christopher M. DeGiorgio, M.D., as Vice-President, Neurology. In this new role Dr. DeGiorgio, who was previously a Senior Medical Advisor to the Company, will lead NeuroSigma's development of Trigeminal Nerve Stimulation (TNS) for the treatment of neurological indications. "I am very excited to join NeuroSigma to help move TNS therapy forward as a...

2012-03-08 09:05:00

ST. PAUL, Minn., March 8, 2012 /PRNewswire/ -- Three articles have recently been published showing positive results from the Apnex Hypoglossal Nerve Stimulation (HGNS®) System clinical studies in the United States and Australia. The most recent article by Dr. George Goding et al. was published online in February 2012 in the Otolaryngology Head Neck Surgery journal.(1) This study examined the acute effects of HGNS therapy using fluoroscopic imaging, and it showed that the HGNS System...

2012-03-06 12:45:00

Stryker´s Acquisition of Boston Scientific´s Neurovascular Division Propels Company to Lead Neuroradiology Markets According to an iData Research Report Vancouver, BC (PRWEB) March 06, 2012 According to a new report by iData Research (http://www.idataresearch.net), the leading global authority in medical device market research, the U.S. neurological device market, was valued at over $2.7 billion in 2011. By 2018, the market is expected to reach over $5.3 billion, fueled by the...

Scientists Confirm Yoga Can Reduce Stress, Medical And Psychological Conditions
2012-03-07 11:12:55

A new study provides a theory for how stress-related and psychological conditions may be reduced with yoga. Researchers from Boston University School of Medicine (BUSM), Columbia College of Physicians and Surgeons (CCPS), and the New York Medical College (NYMC) posted their theory and findings in the journal Medical Hypothesis. The researchers believe that yoga, in conjunction with standard medical practices, can provide aid and relief for many medical and psychological conditions, such...

2012-03-06 08:00:00

HOUSTON, March 6, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the Sidoti 16th Annual Emerging Growth Research Institutional Investor Forum on Tuesday, March 20, 2012, in New York. Dan Moore, President & Chief Executive Officer, will speak at 10:40 AM Eastern Time. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM ET on...

2012-02-10 08:00:00

HOUSTON, Feb. 10, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the Citi 2012 Global Health Care Conference on Monday, February 27, 2012, in New York. Greg Browne, Senior Vice President and Chief Financial Officer, will speak at 11:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link...

2012-02-01 08:00:00

HOUSTON, Feb. 1, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the third quarter ended January 27, 2012, of its fiscal year ending April 27, 2012, on Friday, February 24, 2012, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2012 Third Quarter Results Conference Call InstructionsThe...

2012-01-03 08:00:00

HOUSTON, Jan. 3, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011. "We are pleased that the FDA was able to complete its review in approximately 60 days, enabling us to resume our limited commercial release of the AspireHC generator in the United States," said Dan Moore,...

2011-12-01 08:00:00

HOUSTON, Dec. 1, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced that it will host an investor and analyst meeting on Thursday, December 8, 2011, from 9:30 am - 1:30 pm Eastern Time, at Cyberonics' corporate headquarters in Houston, Texas. This meeting will be webcast live and by replay. To access the webcast and the presentation slides, please enter the Company's website at http://www.cyberonics.com, and follow the webcast link listed under Investor Relations, Events...

2011-11-16 08:00:00

HOUSTON, Nov. 16, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011, in New York. Dan Moore, President and Chief Executive Officer, and Greg Browne, Senior Vice President and Chief Financial Officer, will speak at 8:30 AM Eastern Time. A live audio webcast of the presentation can be...